Related Experiment Video
Updated: Jun 15, 2026
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines
Ansgar M Chromik1, Adrien Daigeler, Daniel Bulut
1Department of Visceral and General Surgery, St Josef Hospital, Ruhr-University Bochum, Germany. a.chromik@klinikum-bochum.de
Background:
Taurolidine (TRD) represents an anti-infective substance with anti-neoplastic activity in many malignant cell lines. So far, the knowledge about the cell death inducing mechanisms and pathways activated by TRD is limited. The aim of this study was therefore, to perform a comparative analysis of cell death induction by TRD simultaneously in different malignant cell lines.
Materials And Methods:
Five different malignant cell lines (HT29/Colon, Chang Liver/Liver, HT1080/fibrosarcoma, AsPC-1/pancreas and BxPC-3/pancreas) were incubated with increasing concentrations of TRD (100 microM, 250 microM and 1000 microM) for 6 h and 24 h. Cell viability, apoptosis and necrosis were analyzed by FACS analysis (Propidiumiodide/AnnexinV staining). Additionally, cells were co-incubated with the caspase Inhibitor z-VAD, the radical scavenger N-Acetylcystein (NAC) and the Gluthation depleting agent BSO to examine the contribution of caspase activation and reactive oxygen species in TRD induced cell death.
Results:
All cell lines were susceptible to TRD induced cell death without resistance toward this anti-neoplastic agent. However, the dose response effects were varying largely between different cell lines. The effect of NAC and BSO co-treatment were highly different among cell lines--suggesting a cell line specific involvement of ROS in TRD induced cell death. Furthermore, impact of z-VAD mediated inhibition of caspases was differing strongly among the cell lines.
Conclusion:
This is the first study providing a simultaneous evaluation of the anti-neoplastic action of TRD across several malignant cell lines. The involvement of ROS and caspase activation was highly variable among the five cell lines, although all were susceptible to TRD induced cell death. Our results indicate, that TRD is likely to provide multifaceted cell death mechanisms leading to a cell line specific diversity.
Insights
Taurolidine (TRD) effectively induces cell death in various cancer cell lines, but the mechanisms vary by cell type. This study reveals TRD
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Taurolidine (TRD) is an anti-infective with demonstrated anti-neoplastic properties.
- Limited understanding exists regarding the specific cell death pathways activated by TRD.
Purpose of the Study:
- To comparatively analyze the cell death induction mechanisms of TRD across multiple malignant cell lines.
- To investigate the roles of reactive oxygen species (ROS) and caspase activation in TRD-induced cytotoxicity.
Main Methods:
- Five distinct cancer cell lines were treated with varying concentrations of TRD (100–1000 µM) for 6 and 24 hours.
- Cell viability, apoptosis, and necrosis were assessed using FACS analysis (Propidium Iodide/Annexin V staining).
- Co-incubation with caspase inhibitor z-VAD, radical scavenger N-Acetylcysteine (NAC), and glutathione-depleting agent BSO was performed to elucidate mechanisms.
Main Results:
- All tested cell lines exhibited susceptibility to TRD-induced cell death, with no observed resistance.
- Dose-response effects and the involvement of ROS and caspase activation in TRD-induced cell death varied significantly among cell lines.
- NAC and BSO co-treatments demonstrated cell-line-specific roles for ROS, while z-VAD inhibition highlighted variable caspase involvement.
Conclusions:
- This study provides the first simultaneous evaluation of TRD's anti-neoplastic effects across diverse malignant cell lines.
- TRD induces cell death through multifaceted mechanisms with cell-line-specific variations in ROS and caspase pathway involvement.
- The findings suggest that TRD's efficacy is dependent on cell-specific responses to its cytotoxic pathways.
More Related Videos
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012